High-sensitivity niche Brava Diagnostics offers a high-sensitivity troponin point-of-care solution tailored for emergency medicine, presenting a clear angle to target EDs and urgent care networks seeking rapid, lab-quality results within 15 minutes.

Speed and accuracy Position the platform as the only POC system combining rapid turnaround with high analytical sensitivity, addressing the ongoing gap between traditional central lab timelines and current POC performance.

Clinical guidelines fit Align messaging with ESC and ACC guideline shifts toward hs-cTn assays to capture demand from hospitals upgrading troponin testing, enabling buyers to meet regulatory and clinical benchmarks.

De-risked tech Leverage MBio’s decade of core technology and prior commercialization outside human health as proof of feasibility and potential for faster regulatory navigation and lower development risk.

Strategic partnerships Target academic medical centers, regional health systems, and diagnostic service providers with a compelling ROI narrative around faster triage, improved patient flow, and potential cost savings per ED visit.